Hanson & Doremus Investment Management’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History
Bought
Maintained
Sold
Other funds holding BSX.PRA
Hanson & Doremus Investment Management's BSX.PRA Position: Q1 2023 in Review
Hanson & Doremus Investment Management sold out of Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A (BSX.PRA) in Q1 2023, closing a stake of 134 shares — an estimated $15K sold.
Hanson & Doremus Investment Management first reported a position in BSX.PRA in Q2 2022 and held it in 2 quarters. The position peaked at $15K in Q4 2022. 56 funds tracked by Wall St. Rank hold BSX.PRA as of Q1 2023.
- Hanson & Doremus Investment Management reported no remaining Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position as of Q1 2023 after selling out during the quarter.
- Hanson & Doremus Investment Management sold 134 Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A shares in Q1 2023, an estimated $15K.
- Hanson & Doremus Investment Management first reported a position in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A in Q2 2022 and held it in 2 quarters.
- Hanson & Doremus Investment Management's Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position peaked at $15K in Q4 2022.
- 56 funds tracked by Wall St. Rank held Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A as of Q1 2023.
Based on Hanson & Doremus Investment Management's 13F filing for Q1 2023, filed 18 Apr 2023.